GO
Loading...

Teva Pharmaceutical Industries Ltd

More

  • Generic Drug Sales Strive Despite Recession Monday, 23 Feb 2009 | 12:36 PM ET

    Despite the ongoing recession, generic drug makers like Teva Pharmaceutical and Watson Pharmaceutical have been outperforming in the broader market. CEOs William Marth and Paul Bisaro both expect to see further growth.

  • Prep Your Portfolio For Surprise Stock Recovery Thursday, 19 Feb 2009 | 2:40 PM ET

    Dan Genter thinks the markets may be bumping along the bottom until the end of this year or the beginning of 2010, but then, equities will be the place to be, and now is the time to get positioned.  He feels the framework for recovery is now being built.

  • Stem Cell Summit Tuesday, 17 Feb 2009 | 6:38 PM ET

    Which firms are racing to the forefront of this bold new science?

  • Market 360: The Week's Best & Worst Friday, 13 Feb 2009 | 4:39 PM ET

    On a week dominated by the $787B stimulus plan passed by the House, with the Senate scheduled to start the vote at 5:30pET Friday, the markets came close to retesting their November lows to end the week down 3.5% or greater.

  • The "Big Bank Theory" Of Picking Stocks Thursday, 12 Feb 2009 | 1:33 PM ET

    CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.

  • Expansionary Stocks For a Recessionary Economy Friday, 6 Feb 2009 | 10:37 AM ET

    Cozad Asset Management's Ron Kiddoo thinks there's an upside to the downside. "I think we're facing a recessionary economy, so we would look at recessionary stocks, such as in health care and consumer staples," he told CNBC. "Perhaps a little bit in the industrial sector..."

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Amgen Options Boiling on M&A Rumors Monday, 2 Feb 2009 | 5:14 PM ET

    Call options are heating up in Amgen, which is up slightly Monday in a sluggish market. As AMGN trades at about $55.20 the Febuary 57.5 and 60 calls are drawing a few nibbles, but most of today's action involves the Febuary 65 calls. What's it mean?

  • Health Care Hopping Into 2009? Tuesday, 30 Dec 2008 | 6:54 PM ET

    Merck, Lilly and Pfizer are all trading substantially higher. Will this bear market remedy keep working in the new year?

  • Stocks Fall On Fear Fed Out Of Bullets Wednesday, 17 Dec 2008 | 5:32 PM ET

    The Dow fell on Wednesday as investors continued to digest whether the Fed had any more ammunition left after its bold move on Tuesday...

  • Buy Energy and Healthcare Stocks: Strategist Thursday, 11 Dec 2008 | 3:36 PM ET

    Dan Genter at RNC Genter Capital Management said the bull market will return soon and it’s time for investors to start “brining their heads up out of the fox hole and start tiptoeing through the mine field” to buy into some sectors that have been beat up.

  • Cramer makes the call on viewers' favorite stocks.

  • Market Insider: Thursday Look Ahead Wednesday, 5 Nov 2008 | 9:26 PM ET

    Thursday's chain store sales numbers could set the tone for a market obsessed with the weakening economy.

  • Stock Picks: Energy, Healthcare & Financials Wednesday, 1 Oct 2008 | 12:41 PM ET

    Dan Genter, of RNC Genter Capital Mangement, believes Congress will pass a bailout package by the end of the week, but he expects the next day or two to be wildly volatile and painful. Despite this, he sees opportunities in stocks that have been unjustly beat up.

  • What the Pros Say: Diversity & Dividends Wednesday, 1 Oct 2008 | 8:38 AM ET
    WALL STREET IN CRISIS - A CNBC SPECIAL REPORT

    With Congress rejecting a Wall Street bailout, markets are turning towards central banks hoping they will stop the decline.

  • S&P Slammed Monday, 22 Sep 2008 | 5:56 PM ET

    The Dow tumbled on Monday as investors worried a $700 billion bailout for the financial sector may not resuscitate a slumping economy...

  • Lightning Round OT: Teva Pharma, Gushan and More Wednesday, 17 Sep 2008 | 6:36 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Options Flag Watson As Takeover Target Thursday, 14 Aug 2008 | 8:54 AM ET

    Options action on Watson Phamaceuticals indicates that traders think it might be a takeover target, according to one options experts

  • Buy Biotech Monday, 11 Aug 2008 | 11:38 PM ET

    Cramer offers up five reasons why this sector is the best one to own through the fall. Plus, the top stocks in the group.

  • As we enter day two of the qualifying rounds, all major indices were down but Australia's ASX has taken the lead, followed by India's Bombay Sensex.  In our poll's early voting, many of you suggested that Israel's T25 might be in contention for a medal despite a rough couple of days.  Here are some stats and stocks from Israel.